"Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology"

Mall R.; Bynigeri R.R.; Karki R.; Malireddi R.K.S.; Sharma B.R.; Kanneganti T.-D., Nucleic Acids Research Cancer, 2022, 4(4), zcac033

"Innate immunity, cytokine storm, and inflammatory cell death in COVID-19"

Karki R.; Kanneganti T.-D., Journal of translational medicine, 2022, 20(1), 542

"Molecular mechanism of RIPK1 and caspase-8 in homeostatic type I interferon production and regulation"

Wang Y.; Karki R.; Mall R.; Sharma B.R.; Kalathur R.C.; Lee S.; Kancharana B.; So M.; Combs K.L.; Kanneganti T.-D., Cell reports, 2012 Oct, 4;41(1), 111434

"Single cell analysis of PANoptosome cell death complexes through an expansion microscopy method"

Wang Y.; Pandian N.; Han J.-H.; Sundaram B.; Lee S.J.; Karki R.; Guy C.S.; Kanneganti T.-D., Cellular and Molecular Life Sciences, 2022 Sep 28, 79(10), 531

"ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection"

Karki R.#; Lee S.#; Mall R.; Pandian N.; Wang Y.; Sharma B.R.; Malireddi R.K.S.; Yang D.; Trifkovic S.; Steele J.A.; Connelly J.P.; Vishwanath G.; Sasikala M.; Reddy D.N.; Vogel P.; Pruett-Miller S.M.; Webby R.; Jonsson C.B.; Kanneganti T.-D., Science Immunology, 2022 Aug, 26;7(74), eabo6294

"NLRC4 Deficiency Leads to Enhanced Phosphorylation of MLKL and Necroptosis"

Sundaram B.; Karki R.; Kanneganti T.-D., Immuno Horizons, 2022 Mar, 17;6(3), 243-252

"The Transcription Factor IRF9 Promotes Colorectal Cancer via Modulating the IL-6/STAT3 Signaling Axis"

Sharma B.R.†; Karki R.†; Sundaram B.; Wang Y.; Vogel P.; Kanneganti T.-D.*, Cancers, 2022 Feb, 14(4), 919